Cite
HARVARD Citation
MacKenna, B. et al. (2022). Risk of severe COVID-19 outcomes associated with immune-mediated inflammatory diseases and immune-modifying therapies: a nationwide cohort study in the OpenSAFELY platform. Lancet. pp. e490-e506. [Online].